Found 8 matching trials
Irofulven in Treating Patients With Metastatic Colorectal Cancer
PHASE2RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Location
University of Texas - MD Anderson Cancer Center
Irofulven in Treating Patients With Relapsed or Refractory Non-small Cell Lung Cancer
PHASE2RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Location
Veterans Affairs Medical Center - Birmingham
6-Hydroxymethylacylfulvene in Treating Patients With Metastatic Kidney Cancer
PHASE2RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Location
Memorial Sloan-Kettering Cancer Center
Irofulvene in Treating Patients With Stage III or Stage IV Pancreatic Cancer
PHASE2RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Location
University of Nebraska Medical Center
Irofulven in Treating Patients With Recurrent or Persistent Ovarian Epithelial or Primary Peritoneal Cancer
PHASE2Phase II trial to study the effectiveness of irofulven in treating patients...
Location
Gynecologic Oncology Group
Irofulven in Treating Patients With Stage IVB or Recurrent Cervical Cancer
PHASE2RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Location
Multiple Locations
Irofulven in Treating Children With Recurrent or Refractory Solid Tumors
PHASE1Phase I trial to study the effectiveness of irofulven in treating children ...
Location
University of Arkansas for Medical Sciences
6-Hydroxymethylacylfulvene in Treating Patients With Refractory Myelodysplastic Syndrome, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Blastic Phase Chronic Myelogenous Leukemia
PHASE1Phase I trial to study the effectiveness of 6-hydroxymethylacylfulvene in t...
Location
University of Texas - MD Anderson Cancer Center